Hydroxypropylmethylcellulose + Carboxymethylcellulose
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Dry Eye Syndromes
Conditions
Dry Eye Syndromes
Trial Timeline
Mar 1, 2011 → Jan 1, 2012
NCT ID
NCT01280110About Hydroxypropylmethylcellulose + Carboxymethylcellulose
Hydroxypropylmethylcellulose + Carboxymethylcellulose is a approved stage product being developed by Merck for Dry Eye Syndromes. The current trial status is completed. This product is registered under clinical trial identifier NCT01280110. Target conditions include Dry Eye Syndromes.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01280110 | Approved | Completed |
Competing Products
20 competing products in Dry Eye Syndromes